As of Feb 05
| -1.31 / -1.87%|
The 19 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 80.00, with a high estimate of 96.00 and a low estimate of 74.00. The median estimate represents a +16.60% increase from the last price of 68.61.
The current consensus among 23 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.